Medication Management in Early Psychosis and At-risk States-Presentation And Q&A

Video Transcription

Video Summary

The video is a webinar on medication in early psychosis. Hosted by Judith Doberman, the program manager for PEPMED at Stanford University School of Medicine, the webinar features guest speakers Dr. Kate Hardy and Dr. Steven Adelsheim. It is a partnership between PEPMED and SMI Advisor, a SAMHSA-funded initiative implemented by the American Psychiatric Association. Dr. Jacob Ballin, an expert in the treatment of psychotic disorders, presents the webinar and covers topics including medication choices, newer medications, considerations in medication use, and involving families in decision-making. He emphasizes shared decision-making, communication, and the clinical high-risk stage. The webinar aims to educate clinicians and healthcare professionals involved in early psychosis care.<br /><br />Moving on to medication for schizophrenia in the first episode, the presenter discusses the APA treatment guidelines and their controversy. They introduce their own book on psychopharmacology for people in early psychosis. Factors in choosing an initial medication, such as family history and side effect risks, are discussed, along with the individual's goals and day-to-day activities. They also touch on long-acting injectable medications, mentioning the benefits and challenges. Limited data on the impact of race or ethnicity on medication efficacy is mentioned, particularly regarding clozapine in black individuals. The presenter briefly mentions emerging medications and potential future treatments.<br /><br />Monitoring for side effects, especially weight gain and movement-related side effects, is emphasized. Adjunctive medications like antidepressants and stimulants for managing symptoms are discussed. The importance and potential benefits of exercise for individuals with psychosis and mood disorders are also highlighted.<br /><br />In summary, the video provides an overview of medication options and considerations for the first episode of schizophrenia. It discusses emerging treatments and the importance of holistic care, with no credits mentioned.

Keywords

medication

early psychosis

webinar

PEPMED

Stanford University School of Medicine

schizophrenia

APA treatment guidelines

psychopharmacology

family history

side effects

exercise